deferiprone has been researched along with Congenital Erythropoietic Porphyria in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with deferiprone of UROS-deficient erythroid cell lines and peripheral blood CD34+-derived erythroid cultures from a patient with CEP inhibited iron-dependent protein ALAS2 and iron-responsive element-binding protein 2 expression and reduced porphyrin production." | 1.56 | Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria. ( Bedel, A; Blouin, JM; Costet, P; Daher, R; Ged, C; Gouya, L; Karim, Z; Lalanne, M; Lamrissi-Garcia, I; Moreau-Gaudry, F; Morice-Picard, F; Puy, H; Richard, E, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blouin, JM | 1 |
| Ged, C | 1 |
| Lalanne, M | 1 |
| Lamrissi-Garcia, I | 1 |
| Morice-Picard, F | 1 |
| Costet, P | 1 |
| Daher, R | 1 |
| Moreau-Gaudry, F | 1 |
| Bedel, A | 1 |
| Puy, H | 1 |
| Gouya, L | 1 |
| Karim, Z | 1 |
| Richard, E | 1 |
1 other study available for deferiprone and Congenital Erythropoietic Porphyria
| Article | Year |
|---|---|
Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria.
Topics: 5-Aminolevulinate Synthetase; Adult; Anemia, Hemolytic; Animals; Cell Line; Cell Line, Tumor; CRISPR | 2020 |